FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Charles E. Hart, chief scientific officer, will provide an update of corporate activities at the Stanford Group Company Annual Healthcare Conference on Thursday, January 17 at 1:45 p.m. Eastern Time. The conference is being held at the Four Seasons Hotel in Washington D.C.
